Nemaura Medical Inc. (NASDAQ: NMRD) Diabetes, Obesity Solutions Differentiated in Form and Function
September 24 2021 - 8:30AM
NetworkNewsAudio --
Nemaura Medical Inc. (NASDAQ: NMRD)
announces the availability of a broadcast
titled, “Healthcare Technologies Spearheading Modern Medicine
Movement, Providing Hope to Throttle Diabetes, Obesity.”
To hear the AudioPressRelease, please visit The
NetworkNewsAudio News Podcast.
To view the full editorial, please
visit https://nnw.fm/aKQpJ.
Globally, 463 million people have diabetes. Data from the World
Health Organization shows that diabetes kills about 3.4 million
people worldwide each year. The actual number of deaths where
diabetes is the culprit can be difficult to discern because
diabetics typically grow progressively more ill, with high blood
sugar damaging the heart, blood vessels, kidneys, eyes and
nerves.
Nemaura Medical Inc. (NASDAQ: NMRD) has spent the last
decade developing the world’s first daily-wear, noninvasive glucose
sensor and integrated healthcare app. The company’s BEAT(R)
diabetes platform, inclusive of sugarBEAT(R) CGM and proBEAT(TM),
which combines noninvasive glucose data processed using artificial
intelligence (AI) and a digital healthcare subscription service, is
clearly differentiated from others in form and function.
About Nemaura Medical Inc.
Nemaura Medical is a medical technology company developing and
commercializing non-invasive wearable diagnostic devices. The
company is currently commercializing sugarBEAT(R) and proBEAT(TM).
sugarBEAT, a CE-mark-approved Class IIb medical device, is a
noninvasive and flexible continuous glucose monitor (CGM) providing
actionable insights derived from real-time glucose measurements and
daily glucose trend data, which may help people with diabetes and
prediabetes to better manage, reverse and prevent the onset of
diabetes. Nemaura has submitted a PMA (premarket approval
application) for sugarBEAT to the U.S. FDA. proBEAT combines
noninvasive glucose data processed using artificial intelligence
and a digital health-care subscription service and has been
launched in the United States as a general wellness product as part
of its BEAT(R) diabetes program.
For more information, please
visit www.NemauraMedical.com.
NOTE TO INVESTORS: The latest news and
updates relating to NMRD are available in the company’s newsroom
at https://ibn.fm/NMRD.
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides
(1) access to our news aggregation and syndication servers,
(2) NetworkNewsBreaks that summarize corporate news and
information, (3) enhanced press release services, (4) social media
distribution and optimization services, and (5) a full array of
corporate communication solutions. As a multifaceted financial news
and content distribution company with an extensive team of
contributing journalists and writers, NNW is uniquely positioned to
best serve private and public companies that desire to reach a wide
audience of investors, consumers, journalists and the general
public. NNW has an ever-growing distribution network of more than
5,000 key syndication outlets across the country. By cutting
through the overload of information in today’s market, NNW brings
its clients unparalleled visibility, recognition and brand
awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS”
to 77948 (U.S. Mobile Phones Only).
For more information please
visit https://www.NetworkNewsWire.com.
Please see full terms of use and disclaimers on the
NetworkNewsWire website applicable to all content provided by NNW,
wherever published or
re-published: http://NNW.fm/Disclaimer.
NetworkNewsWire (NNW) New York, New York
www.NetworkNewsWire.com 212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.
Nemaura Medical (NASDAQ:NMRD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Nemaura Medical (NASDAQ:NMRD)
Historical Stock Chart
From Jul 2023 to Jul 2024